SYNEOS HEALTH INC's ticker is SYNH and the CUSIP is 87166B102. A total of 286 filers reported holding SYNEOS HEALTH INC in Q2 2020. The put-call ratio across all filers is 0.53 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $215 | +31.1% | 5,101 | +10.8% | 0.01% | +25.0% |
| Q1 2023 | $164 | -4.1% | 4,605 | -1.5% | 0.01% | -11.1% |
| Q4 2022 | $171 | -99.9% | 4,675 | +2.1% | 0.01% | -25.0% |
| Q3 2022 | $216,000 | -35.3% | 4,580 | -1.7% | 0.01% | -29.4% |
| Q2 2022 | $334,000 | -13.5% | 4,660 | -2.3% | 0.02% | 0.0% |
| Q1 2022 | $386,000 | -31.1% | 4,768 | -12.6% | 0.02% | -22.7% |
| Q4 2021 | $560,000 | -0.7% | 5,455 | -15.4% | 0.02% | -8.3% |
| Q3 2021 | $564,000 | -9.2% | 6,446 | -7.2% | 0.02% | -14.3% |
| Q2 2021 | $621,000 | +13.7% | 6,943 | -3.5% | 0.03% | 0.0% |
| Q1 2021 | $546,000 | -7.6% | 7,198 | -17.0% | 0.03% | -15.2% |
| Q4 2020 | $591,000 | +47.4% | 8,674 | +14.9% | 0.03% | +26.9% |
| Q3 2020 | $401,000 | -7.6% | 7,546 | +1.2% | 0.03% | -18.8% |
| Q2 2020 | $434,000 | +63.2% | 7,454 | +10.6% | 0.03% | +39.1% |
| Q1 2020 | $266,000 | -39.4% | 6,737 | -8.8% | 0.02% | -23.3% |
| Q4 2019 | $439,000 | – | 7,389 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADVENT INTERNATIONAL, L.P. | 15,418,795 | $1,050,483,000 | 52.20% |
| THOMAS H LEE PARTNERS LP | 13,238,542 | $901,942,000 | 25.86% |
| BLOOM TREE PARTNERS, LLC | 648,690 | $44,195,000 | 3.07% |
| Endurant Capital Management LP | 101,953 | $6,946,000 | 2.50% |
| Sapience Investments, LLC | 246,510 | $16,795,000 | 2.34% |
| HealthCor Management, L.P. | 793,320 | $54,049,000 | 2.08% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 871,025 | $59,343,000 | 1.73% |
| DALTON GREINER HARTMAN MAHER & CO | 114,857 | $7,825,000 | 1.65% |
| COOKE & BIELER LP | 2,071,831 | $141,154,000 | 1.54% |
| FORMULA GROWTH LTD | 118,133 | $8,048,000 | 1.34% |